107 related articles for article (PubMed ID: 10398081)
1. Urinary tissue factor levels in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
[TBL] [Abstract][Full Text] [Related]
2. Urinary tissue factor levels in patients with bladder and prostate cancer.
Lwaleed BA; Francis JL; Chisholm M
Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
[TBL] [Abstract][Full Text] [Related]
3. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity.
Lwaleed BA; Francis JL; Chisholm M
J Hematother Stem Cell Res; 1999 Dec; 8(6):659-68. PubMed ID: 10645774
[TBL] [Abstract][Full Text] [Related]
5. The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
Br J Cancer; 1999 Apr; 80(1-2):279-85. PubMed ID: 10390009
[TBL] [Abstract][Full Text] [Related]
6. Urinary tissue factor: a potential marker of disease.
Lwaleed BA; Bass PS; Francis JL
J Pathol; 1999 May; 188(1):3-8. PubMed ID: 10398132
[TBL] [Abstract][Full Text] [Related]
7. Procoagulant activity in whole blood from patients with breast and colorectal cancer.
Parmar J; Taylor I; Roath S; Francis J
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):127-32. PubMed ID: 2130924
[TBL] [Abstract][Full Text] [Related]
8. Urinary tissue factor levels in neoplastic diseases.
Lwaleed BA; Francis JL; Chisholm M
Ann Saudi Med; 2000; 20(3-4):197-201. PubMed ID: 17322656
[TBL] [Abstract][Full Text] [Related]
9. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
12. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.
Ueno T; Toi M; Koike M; Nakamura S; Tominaga T
Br J Cancer; 2000 Jul; 83(2):164-70. PubMed ID: 10901365
[TBL] [Abstract][Full Text] [Related]
15. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
16. Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.
Frenkel K; Karkoszka J; Glassman T; Dubin N; Toniolo P; Taioli E; Mooney LA; Kato I
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):49-57. PubMed ID: 9456243
[TBL] [Abstract][Full Text] [Related]
17. [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].
Fu WJ; Zheng L; Wang Q; Deng RT; Ye CQ; Wang SB; Peng LF; Xiong SL; Tang HH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):878-81. PubMed ID: 21602148
[TBL] [Abstract][Full Text] [Related]
18. Comparison of some trace elements concentration in blood, tumor free breast and tumor tissues of women with benign and malignant breast lesions: an Indian study.
Siddiqui MK; Jyoti ; Singh S; Mehrotra PK; Singh K; Sarangi R
Environ Int; 2006 Jul; 32(5):630-7. PubMed ID: 16580070
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of protein Z detection in patients with malignant tumors].
Shang Y; Pan XY; Ding CP; Yang XM; Cai XY; Ding Y; Zhang RL
Ai Zheng; 2005 Sep; 24(9):1144-7. PubMed ID: 16159443
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
